Irritable bowel syndrome, anxiety, and depression: What are the links?

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 8, 2001, Pages 38-47

  Lydiard, R Bruce ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ATROPINE; BENZODIAZEPINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DIAZEPAM; FLUPHENAZINE; MIANSERIN; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ABDOMINAL PAIN; ANXIETY NEUROSIS; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GASTROINTESTINAL TRACT FUNCTION; HUMAN; IRRITABLE COLON; MENTAL STRESS; NEUROBIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANXIETY DISORDERS; COLONIC DISEASES, FUNCTIONAL; COMORBIDITY; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; FEMALE; HUMANS; LIFE CHANGE EVENTS; MALE; PANIC DISORDER; PATIENT ACCEPTANCE OF HEALTH CARE; PHOBIC DISORDERS; PREVALENCE; PSYCHOTROPIC DRUGS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0343371688     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Connell AM, Hilton C, Irvine G, et al. Variation of bowel habit in two population samples. BMJ 1965;5470:1095-1099
2. Drossman DA, Lowman BC. Irritable bowel syndrome: epidemiology, diagnosis and treatment. Clin Gastroenterol 1985;14:559-573
3. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980;79:283-288
4. Drossman DA, Thompson WG, Talley NJ, et al. Identification of subgroups of functional gastrointestinal disorders. Gastroenterol Int 1990;3:159-172
5. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45(suppl 2):111-115
6. Fielding JF. The irritable bowel syndrome, pt 1: clinical spectrum. Clin Gastroenterol 1977;6:607-622
7. Hislop IG. Psychological significance of the irritable colon syndrome. Gut 1971;12:452-457
8. Sandler RS, Drossman DA, Nathan HP, et al. Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology 1984;87:314-318
9. Whitehead WE, Bosmajian L, Zonderman AB, et al. Symptoms of psychologic distress associated with irritable bowel syndrome: comparison of community and mecical clinic samples. Gastroenterology 1988;95: 709-714
10. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-1580
11. Whitehead WE, Schuster MM, eds. Gastrointestinal Disorders: Behavioral and Physiological Basis for Treatment. New York, NY: Academic Press; 1985
12. Norton N. Functional Bowel Disorders Survey. Participate 1997;6:1-3
13. Drossman DA, Sandler RS, McKee DC, et al. Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology 1982;83:529-534
14. Drossman DA. Irritable bowel syndrome: a multifunctional disorder. Hosp Pract (Off Ed) 1988;23:119-124,126,131-133
15. Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci 1987;32:841-845
16. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-708
17. Esler MD, Goulston KJ. Levels of anxiety in colonic disorders. N Engl J Med 1973;288:16-20
18. Clouse RE, Alpers DH. The relationship of psychiatric disorder to gastrointestinal illness. Annu Rev Med 1986;37:283-295
19. Blanchard EB, Scharff L, Schwarz SP, et al. The role of anxiety and depression in the irritable bowel syndrome. Behav Res Ther 1990;28:401-405
20. Fava GA, Pavan L. Large bowel disorders, 2: psychopathology and alexithymia. Psychother Psychosom 1976;27:100-105
21. Creed F. The relationship between psychosocial parameters and outcome in the irritable bowel syndrome. Am J Med 1999;107(suppl 5A):74-80
22. Ford MJ, Miller PM, Eastwood J, et al. Life events, psychiatric illness and the irritable bowel syndrome. Gut 1987;28:160-165
23. Latimer PR. Irritable bowel syndrome: a behavioral model. Behav Res Ther 1981;19:475-483
24. Liss JL, Alpers D, Woodruff RJ. The irritable colon syndrome and psychiatric illness. Dis Nerv Syst 1973;34:151-157
25. Lydiard RB, Fossey MD, Marsh W, et al. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics 1993;34: 229-234
26. Walker EA, Roy-Byrne PP, Katon WJ, et al. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease. Am J Psychiatry 1990;147:1656-1661
27. Wender PH, Kalm M. Prevalence of attention deficit disorder, residual type, and other psychiatric disorders in patients with irritable colon syndrome. Am J Psychiatry 1983;140:1570-1582
28. Toner BB, Garfinkel PE, Jeejeebhoy KN. Psychological factors in irritable bowel syndrome. Can J Psychiatry 1990;35:158-161
29. Young SJ, Alpers DH, Norland CC, et al. Psychiatric illness and the irritable bowel syndrome: practical implications for the primary physician. Gastroenterology 1976;70:162-166
30. Whitehead WE. Psychosocial aspects of functional gastrointestinal disorders. Gastroenterol Clin North Am 1996;25:21-34
31. Walker EA, Gelfand AN, Gelfand MD, et al. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995;25: 1259-1267
32. Irwin C, Falsetti SA, Lydiard RB, et al. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. J Clin Psychiatry 1996;57:576-578
33. Blewett A, Allison M, Calcraft B, et al. Psychiatric disorder and outcome in irritable bowel syndrome. Psychosomatics 1996;37:155-160
34. Lydiard RB. Anxiety and the irritable bowel syndrome: psychiatric, medical, or both? J Clin Psychiatry 1997;58(suppl 3):51-58; discussion 59-61
35. Tollefson GD, Luxenberg M, Valentine R, et al. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder. J Clin Psychiatry 1991;52:502-508
36. Noyes RJ, Cook B, Garvey M, et al. Reduction of gastrointestinal symptoms following treatment for panic disorder. Psychosomatics 1990;31: 75-79
37. Kaplan DS, Masand PS. Gupta S. The relationship of irritable bowel syndrome (IBS) and panic disorder. Ann Clin Psychiatry 1996;8:81-88
38. Maunder RG. Panic disorder associated with gastrointestinal disease: review and hypotheses. J Psychosom Res 1998;44:91-105
39. Lydiard RB, Fossey MD, Ballenger JC. Irritable bowel syndrome in patients with panic disorder [letter; comment]. Am J Psychiatry 1991;148: 1614
40. Lydiard RB, Greenwald S, Weissman MM, et al. Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry 1994;151:64-70
41. Walker EA, Katon WJ, Jemelka RP, et al. Comorbidity of gastrointestinal complaints, depress on, and anxiety in the Epidemiologic Catchment Area (ECA) study. Am J Med 1992;92:26S-30S
42. Lydiard RB, Falsetti SF. Experience with anxiety and depression treatment studies: implications for designing IBS clinical trials. Am J Med 1999; 107:65S-73S
43. Drossman DA, Leserman J, Nachman G. et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. Ann Intern Med 1990;113:828-833
44. Walker EA, Katon WJ, Roy BP, et al. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease. Am J Psychiatry 1993;150:1502-1506
45. Felliti V. Long term medical consequences of incest, rape and molestation. South Med J 1991;84:328-331
46. Talley NJ, Hegelson S, Zinsmeister AR. Are sexual and physical abuse linked to functional gastrointestinal disorders? Gastroenterology 1992;102: A523
47. Lechner M, Vogel M, Garcia-Shelton L, et al. Self-reported medical problems of adult female survivors of childhood sexual abuse. J Fam Pract 1993;36:633-638
48. Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? a population-based study. Gut 1998;42:47-53
49. Stam R, Akkermans LMA, Wiegant VM. Trauma and the gut: interactions between stressful experience and intestinal function. Gut 1997;40:704-709
50. Arnold R, Rogers D, Cook D. Medical problems of adults who were sexually abused as children. BMJ 1990;300:705-708
51. Bachman G, Moeller T, Bennett J. Childhood sexual abuse and the consequence in adult women. Obstet Gynecol 1988;71:631-642
52. Haber J, Roos C. Effects of chronic spouse abuse and/or sexual abuse in the development and maintenance of chronic pain in women. Adv Pain Res Ther 1985;9:889-895
53. Rimza M, Berg R, Locke C. Sexual abuse: somatic and emotional reactions. Child Abuse Negl 1988;12:201-208
54. Sedney M, Brooks B. Factors associated with a history of childhood sexual experience in a nonclinical female population. J Am Acad Child Adolesc Psychiatry 1984;9:889-895
55. Leserman J, Li Z, Drossman DA, et al. Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: the impact on subsequent health care visits. Psychol Med 1998;28:417-425
56. Drossman DA. Irritable bowel syndrome and sexual/physical abuse history [comment]. Eur J Gastroenterol Hepatol 1997;9:327-330
57. Walker EA, Unutzer J, Rutter C, et al. Costs of health care use by women HMO members with a history of childhood abuse and neglect. Arch Gen Psychiatry 1999;56:609-613
58. Gershon MD. The enteric nervous system. Annu Rev Neurosci 1981;4: 227-272
59. Gershon MD. The enteric nervous system: a second brain. Hosp Pract (Off Ed) 1999;34:31-32, 35-38, 41-42
60. Gershon MD. Genes and lineages in the formation of the enteric nervous system. Curr Opin Neurobiol 1997;7:101-109
61. Grijalva CV, Novin D. The role of the hypothalamus and dorsal vagal complex in gastrointestinal function and pathophysiology. Ann N Y Acad Sci 1990;597:207-222
62. Coplan J, Lydiard RB. Brain circuits in panic disorder. Biol Psychiatry 1998;44:1264-1276
63. Lang PJ, Bradley MM, Cuthbert BN. Emotion, motivation, and anxiety: brain mechanisms and psychophysiology. Biol Psychiatry 1998;44: 1248-1263
64. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry 1998;44:1229-1238
65. Davis M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 1998;44:1239-1247
66. Valentino RJ, Foote SL, Page ME. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci 1993;697:173-188
67. Van Bockstaele EJ, Aston-Jones G. Integration in the ventral medulla and co-ordination of sympathetic, pain and arousal functions. Clin Exp Hypertens 1995;17:153-165
68. Bremner JD, Krystal JH, Southwick SM, et al. Functional neuroanatomical correlates of the effects of stress on memory. J Trauma Stress 1995;8: 527-553
69. Charney DS, Heninger GR. Noradrenergic function and the mechanism of action of antianxiety treatment, 1: the effect of long-term alprazolam treatment. Arch Gen Psychiatry 1985;42:458-467
70. Jia HG, Rao ZR, Shi JW. An indirect projection from the nucleus of the solitary tract to the central nucleus of the amygdala via the parabrachial nucleus in the rat: a light and electron microscopic study. Brain Res 1994;663:181-190
71. Monnikes H, Schmidt BG, Raybould HE, et al. CRF in the paraventricular nucleus mediates gastric and colonie motor response to restraint stress. Am J Physiol 1992;262:G137-G143
72. Monnikes H, Schmidt BG, Tebbe J, et al. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonie motor function in rats. Brain Res 1994;664:101-108
73. Pavcovich LA, Yang M, Miselis RR, et al. Novel role for the pontine micturition center, Barrington's nucleus: evidence for co-ordination of colonic and forebrain activity. Brain Res 1998;784:355-361
74. Valentino RJ, Curtis AL, Page ME, et al. Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv Pharmacol 1998;42:781-784
75. Elam M, Swensson T, Thoren P. Locus ceruleus in sympathetic nerves: activation by visceral afferents. Brain Res 1986;375:117-125
76. Valentino R. Altered brainstem-forebrain activation. In: Mayer EA, ed. Evolving Pathophysiological Models of Functional GI Disorders: Implications for New Drug Development. New York, NY: Health Education Alliance; 2000:63-66
77. Lechner SM, Curtis AL, Brons R, et al. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res 1997;756:114-124
78. Lydiard RB, Laraia MT, Howell EF, et al. Can panic disorder present as irritable bowel syndrome? J Clin Psychiatry 1986:47:470-473
79. Uhde TW, Boulenger JP, Post RM, et al. Fear and anxiety: relationship to noradrenergic function. Psychopathology 1984;3:8-23
80. Toner BB, Segal ZV, Emmott S, et al. Cognitive-behavioral group therapy for patients with irritable bowel syndrome. Int J Psychother 1998;48:215-243
81. Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York, NY: Guilford Press; 1985
82. Monnikes H, Schmidt BG, Tache Y. Psychological stress-induced accelerated colonie transit in rats involves hypothalamic corticotropin-releasing factor. Gastroenterology 1993;104:716-723
83. Bueno L, Gue M, Delrio C. CNS vasopressin mediates emotional stress and CRH-induced colonie motor alterations in rats. Am J Physiol 1992; 262:G427-G431
84. Tache Y, Martinez V, Million M, et al. Corticotropin-releasing factor and the brain-gut motor response to stress. Can J Gastroenterol 1999; 13(suppl A):18-25
85. Owens MJ, Vargas MA, Nemeroff CB. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders. J Psychiatr Res 1993; 27:209-220
86. Nemeroff CB. The neurobiology of depression. Sci Am 1998;278:42-49
87. Southwick SM, Bremner D, Krystal JH, et al. Psychobiologic research in post-traumatic stress disorder. Psychiatr Clin North Am 1994;17: 251-264
88. King TS, Hunter JO. Anxiety and irritable bowel syndrome [letter; comment]. Lancet 1996;347:617
89. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomie arousal. J Abnorm Psychol 1998;107:179-192
90. Drossman DA. Presidential address: gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;69:258-267
91. Weiss EL, Longhurst JG, Mazure CM. Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates. Am J Psychiatry 1999;156:816-828
92. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 2000;84:1-12
93. Curtis AL, Pavcovich LA, Grigoriadis DE, et al. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus. Neuroscience 1995;65:541-550
94. Cervero FWJ. Visceral nociceptors: a new world order? Trends Neurosci 1992;15:374-378
95. Munakata J, Naliboff B, Harraf F, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997;112:55-63. Correction 1997;113:1054
96. Gwee KA, Graham JC, McKendrick MW, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea [see comments]. Lancet 1996;347:150-153
97. Bradley LA, Richter JE, Scarinci IC, et al. Psychosocial and psychophysical assessments of patients with unexplained chest pain. Am J Med 1992;92(suppl 5A):65-73
98. Mayer EA, Fass R, Fullerton S. Intestinal and extraintestinal symptoms in functional gastrointestinal disorders. Eur J Surg Suppl 1998;583:29-31
99. Mayer EA. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994;107:271-293
100. Whitehead WE, Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology 1998;115:1263-1271
101. Whitehead WE, Crowell MD, Davidoff AL, et al. Pain from rectal distension in women with irritable bowel syndrome: relationship to sexual abuse. Dig Dis Sci 1997;42:796-804
102. Walker EA, Gelfand AN, Gelfand MD, et al. Chronic pelvic pain and gynaecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol 1996;17:39-46
103. Prior A, Whorwell PJ. Gynaecological consultation in patients with the irritable bowel syndrome. Gut 1989;30:996-998
104. Lydiard RB. Psychopharmacological interventions for functional gastrointestinal disorders. In: Olden K, ed. Handbook of Functional Gastrointestinal Disorders. New York, NY: Marcel Dekker; 1996;337-360
105. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Aliment Pharmacol Ther 1999; 13(suppl 2):48-53
106. Emmanuel NP, Lydiard RB, Crawford M. Treatment of irritable bowel syndrome with fluvoxamine. Am J Psychiatry 1997;154:711-712
107. Efremova I, Asnis G. Antidepressants in depressed patients with irritable bowel syndrome. Am J Psychiatry 1998;155:1627-1628
108. Steinhart MJ, Wong PY, Zarr ML. Therapeutic usefulness of amitriptyline in spastic colon syndrome. Int J Psychiatry 1981;11:45-57
109. Greenbaum DS, Mayle JE, Vanegeren LE, et al. Effects of desipramine in irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 1987;32:257-266
110. Rajagopalan M, Kurian G, John J. Symptom relief with amitriptyline in irritable bowel syndrome. Gastroenterol Hepatol 1998;13:738-741
111. Heefner JD, Wilder RM, Wilson ID. Irritable colon and depression. Psychosomatics 1978;19:540-547
112. Myren J, Lovland B, Larssen SE, et al. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984;19:835-843
113. Lancaster-Smith MJ, Prout BJ, Pinto T, et al. Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 1982;86:33-41
114. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder: a double-blind placebo-controlled study with mianserin. Scand J Gasti oenterol 1996;31:318-325
115. Clouse RE, Lustman PJ, Geisman RA, et al. Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 1994;8:409-416